1. cyclic amp signalling pathway. 2. cyclic adp-ribose (cadpr) signalling and nicotinic...
TRANSCRIPT
1. Cyclic AMP signalling pathway. 2. Cyclic ADP-ribose (cADPR) signalling and nicotinic acid–adenine dinucleotide phosphate (NAADP) signalling3. Voltage-operated channels (VOCs) 4. Receptor-operated channels (ROCs) 5. Stimuli that activate phospholipase C (PLC(6. PtdIns 3-kinase signalling7. Nitric oxide (NO)/cyclic GMP signalling 8. Redox signalling. Many receptors act throughNADPH oxidase (NOX9. Mitogen-activated protein kinase (MAPK) 10. Nuclear factor κB(NF-κB) signalling.11. Phospholipase D (PLD) signalling.12. Sphingomyelin signalling pathway13. Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signalling.14. Smad signalling pathway15. Wnt signalling pathways. 16. Hedgehog signalling pathway17. Hippo signalling pathway18. Notch signalling pathway. 19. Endoplasmic reticulum (ER) stress signalling.Theendoplasmicreticulum (ER) stress signalling pathway20. AMP signalling pathway..
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Cyclic AMP signalling pathway
Usually depends upon the activation of G-protein-coupled receptors (GPCRs)
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
adenylyl cyclase structure
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Regulatory properties anddistribution of adenylyl cyclase.
Modified from Table I in Whorton and Sunahara 2003. Reproduced from Handbook of Cell Signaling, Volume 2 (edited by R.A. Bradshaw and E.A. Dennis), Whorton, M.R. and Sunahara, R.K., Adenylyl cyclases, pp. 419--426. Copyright (2003), with permission from Elsevier.
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Organization and function of the cyclic AMP signalling pathway
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Function of the Rho monomericG protein in cell signal transduction.
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Function of the Cdc42 monomeric G protein in signal transduction
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Function of the Arf monomeric G-protein in signal transduction
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Summary of the monomeric G proteins with their guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs).
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department
Peyman Keyhanvar, MD, PhD, MBA, Iran University of Medical SciencesFaculty of Advanced Technologies in Medicine, Nanobiomedicine Department